Skip header and navigation

Refine By

4 records – page 1 of 1.

HIV mother-to-child transmission, mode of delivery, and duration of rupture of membranes: experience in the current era.

https://arctichealth.org/en/permalink/ahliterature123523
Source
Infect Dis Obstet Gynecol. 2012;2012:267969
Publication Type
Article
Date
2012
Author
Siobhan Mark
Kellie E Murphy
Stanley Read
Ari Bitnun
Mark H Yudin
Author Affiliation
Department of Obstetrics and Gynecology, University of Toronto, 92 College Street, Toronto, ON, Canada M5G 1L4. siobhan.mark@gmail.com
Source
Infect Dis Obstet Gynecol. 2012;2012:267969
Date
2012
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Amnion
Antiretroviral Therapy, Highly Active
Cohort Studies
Delivery, Obstetric
Female
HIV Infections - drug therapy - transmission - virology
Humans
Infectious Disease Transmission, Vertical - statistics & numerical data
Labor Onset
Ontario
Predictive value of tests
Pregnancy
Pregnancy Complications, Infectious - drug therapy
Retrospective Studies
Time Factors
Viral Load
Young Adult
Abstract
To evaluate whether the length of time of rupture of membranes (ROM) in optimally managed HIV-positive women on highly active antiretroviral therapy (HAART) with low viral loads (VL) is predictive of the risk of mother to child transmission (MTCT) of the human immunodeficiency virus (HIV).
A retrospective case series of all HIV-positive women who delivered at two academic tertiary centers in Toronto, Canada from January 2000 to November 2010 was completed.
Two hundred and ten HIV-positive women with viral loads
Notes
Cites: Int J Gynaecol Obstet. 1999 Sep;66(3):305-610580685
Cites: Int J Gynaecol Obstet. 2003 Jul;82(1):17-2312834937
Cites: Am J Obstet Gynecol. 1995 Aug;173(2):585-97645638
Cites: N Engl J Med. 1996 Jun 20;334(25):1617-238628356
Cites: JAMA. 1998 Jul 1;280(1):55-609660364
Cites: N Engl J Med. 1999 Apr 1;340(13):977-8710099139
Cites: HIV Med. 2011 Apr;12(4):228-3520726902
Cites: Clin Infect Dis. 2005 Feb 1;40(3):458-6515668871
Cites: Cochrane Database Syst Rev. 2005;(4):CD00547916235405
Cites: Lancet. 2008 Jul 26;372(9635):293-918657708
Cites: Can J Clin Pharmacol. 2009 Winter;16(1):e68-7719151422
Cites: Acta Obstet Gynecol Scand. 2009;88(8):882-719557554
Cites: PLoS One. 2009;4(12):e792519997556
Cites: Lancet. 1999 Mar 27;353(9158):1035-910199349
PubMed ID
22690108 View in PubMed
Less detail

Most women living with HIV can deliver vaginally-National data from Finland 1993-2013.

https://arctichealth.org/en/permalink/ahliterature292676
Source
PLoS One. 2018; 13(3):e0194370
Publication Type
Journal Article
Research Support, Non-U.S. Gov't
Date
2018
Author
Inka Aho
Marja Kaijomaa
Pia Kivelä
Heljä-Marja Surcel
Jussi Sutinen
Oskari Heikinheimo
Author Affiliation
Department of Infectious diseases, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Source
PLoS One. 2018; 13(3):e0194370
Date
2018
Language
English
Publication Type
Journal Article
Research Support, Non-U.S. Gov't
Keywords
Adult
Anti-HIV Agents - therapeutic use
Cesarean Section - adverse effects - statistics & numerical data
Delivery, Obstetric - methods - statistics & numerical data
Female
Finland
HIV - drug effects - isolation & purification - pathogenicity
HIV Infections - drug therapy - transmission - virology
Humans
Infant, Newborn
Infectious Disease Transmission, Vertical - prevention & control - statistics & numerical data
Pregnancy
Pregnancy Complications, Infectious - drug therapy - virology
Registries - statistics & numerical data
Retrospective Studies
Viral Load - drug effects
Abstract
Vaginal delivery has been recommended for more than ten years for women living with HIV (WLWH) with good virological control. However, in Europe most WLWH still deliver by cesarean section (CS). Our aim was to assess the rate of vaginal delivery and the indications for CS in WLWH over 20 years in a setting of low overall CS rate.
This was a retrospective study of all WLWH delivering in Finland 1993-2013. We identified the women by combining national health registers and extracted data from patient files.
The study comprised 212 women with 290 deliveries. Over 35% of the women delivered several children during the study years. During 2000-2013, with consistent viral load monitoring, 80.0% showed HIV viral loads
Notes
Cites: HIV Med. 2017 Jul;18(6):440-443 PMID 28000379
Cites: J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):58-65 PMID 23842074
Cites: AIDS. 2012 Mar 27;26(6):757-63 PMID 22210635
Cites: AIDS. 2014 Apr 24;28(7):1049-57 PMID 24566097
Cites: AIDS. 2014 Nov 13;28(17):2609-18 PMID 25574961
Cites: J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484-94 PMID 11981365
Cites: HIV Med. 2017 Nov;18(10 ):736-747 PMID 28544321
Cites: Am J Obstet Gynecol. 2013 Oct;209(4):335.e1-335.e12 PMID 23791563
Cites: Lancet. 1999 Mar 27;353(9158):1035-9 PMID 10199349
Cites: PLoS One. 2015 Dec 14;10(12):e0144592 PMID 26657902
Cites: HIV Med. 2014 Sep;15 Suppl 4:1-77 PMID 25604045
Cites: AIDS. 1998 Jan 22;12(2):205-10 PMID 9468370
Cites: Infect Dis Obstet Gynecol. 2012;2012:267969 PMID 22690108
Cites: Am J Obstet Gynecol. 2012 Dec;207(6):482.e1-5 PMID 23103331
Cites: Eur J Public Health. 2013 Dec;23(6):1053-8 PMID 23478206
Cites: Semin Perinatol. 2012 Oct;36(5):315-23 PMID 23009962
Cites: N Engl J Med. 1999 Apr 1;340(13):977-87 PMID 10099139
Cites: J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):74-82 PMID 27082506
Cites: J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):287-93 PMID 22227490
Cites: HIV Med. 2010 Jul 1;11(6):368-78 PMID 20059573
Cites: BJOG. 2016 May;123(6):975-81 PMID 26011825
PubMed ID
29566017 View in PubMed
Less detail

Retroviruses and opportunistic infections--16th annual conference. Characteristics and prevention of HIV transmission. 8-11 February 2009, Montréal, QC, Canada.

https://arctichealth.org/en/permalink/ahliterature151648
Source
IDrugs. 2009 Apr;12(4):204-6
Publication Type
Conference/Meeting Material
Date
Apr-2009